BRIEF-RepliCel therapy for pattern baldness proceeds to clinical trial launch in Japan
July 21 (Reuters) - RepliCel Life Sciences Inc :
* RCH-01 product cleared by Japanese regulatory authorities for use in clinical research study launching now in Japan
* Study financed by Shiseido company, each product being injected to be manufactured by Shiseido at facility in Kobe, Japan
* Replicel's cell therapy for pattern baldness proceeds to clinical trial launch in Japan Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2017 All rights reserved.